D

Dyne Therapeutics
D

DYN

29.700
USD
-0.09
(-0.30%)
مغلق
حجم التداول
26,664
الربح لكل سهم
-4
العائد الربحي
-
P/E
-8
حجم السوق
3,022,448,953
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AEE
    1.470
    (1.64%)
    91.190 USD
    DTE
    DTE
    0.670
    (0.56%)
    120.060 USD
    EIX
    EIX
    1.540
    (1.88%)
    83.670 USD
    EXC
    EXC
    0.990
    (2.60%)
    39.130 USD
    F
    FE
    0.670
    (1.64%)
    41.510 USD
    PCG
    PCG
    0.010
    (0.05%)
    21.000 USD
    P
    PPL
    0.495
    (1.49%)
    33.720 USD
    SO
    SO
    1.150
    (1.33%)
    87.920 USD
    W
    WEC
    1.850
    (1.92%)
    97.990 USD
    XEL
    XEL
    0.550
    (0.80%)
    69.470 USD
    المزيد
الأخبار

العنوان: Dyne Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both arein the ongoing phase 1/2 clinical trial.